Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
23.79
-1.88 (-7.31%)
Mar 31, 2025, 10:03 AM EDT - Market open
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,054,528
Market Cap
2.67B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VKTX News
- 5 days ago - Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity - PRNewsWire
- 17 days ago - Viking Therapeutics: No Buyout Needed Now - Seeking Alpha
- 18 days ago - Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in. - Market Watch
- 19 days ago - Viking Therapeutics Is Ready For A Standalone Future - Seeking Alpha
- 19 days ago - Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade) - Seeking Alpha
- 20 days ago - Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735 - PRNewsWire
- 20 days ago - Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade) - Seeking Alpha
- 24 days ago - Stock Picks From Seeking Alpha's February 2025 New Analysts - Seeking Alpha